April 2026 was a very busy month for psychedelic policy in the U.S., with bills progressing through statehouses or falling to the wayside as legislative sessions began to taper off and action from the very top of the federal government. Most notably, on April 18th, President Trump signed an executive order directing various federal departments and agencies to accelerate psychedelic research and…
